-
Featured
Identifying Risk Factors for Type 2 Myocardial Infarction
In one of the first large systematic surveys of the frequency and implications of supply/demand-related Type 2 Myocardial Infarction, a suite of risk factors has been identified to help ensure patients receive proper care.
-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
DNA is not Destiny When it Comes to Heart Attack Risk
A study led by Sekar Kathiresan, MD, of Mass General, has found that having a favorable lifestyle can help those with a high genetic risk of having a heart attack reduce their risk by over 50%.
-
Acetylcholine Derived From B Cells May Protect Against Cardiovascular Disease
B cells in the bone marrow are an important source of acetylcholine, Massachusetts General Hospital researchers have discovered. B cell–derived acetylcholine regulated normal hematopoiesis and limited emergency hematopoiesis in cardiovascular disease by modulating signals produced by the bone marrow stromal niche.
-
Cause of Myocardial Injury Affects Mortality Risk in Patients Hospitalized With COVID-19
Jeremy N. Ruskin, MD, and colleagues found that high-sensitivity troponin T elevation from any cause is a strong predictor of mortality in patients hospitalized with COVID-19, but the odds ratio for patients with elevation due to a primary cardiac etiology was 4.6 compared with 2.7 for patients without.
-
Acute MI Survivors with Kidney Failure Have Increased Risk of HF Hospitalization
Srikanth Yandrapalli, MD, a clinical and research fellow in Interventional Cardiology, and colleagues determined that survivors of acute myocardial infarction with either acute or chronic kidney failure have 52%–99% greater odds of hospitalization for heart failure within six months than those without kidney disease.
Myocardial Infarction Contributors
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Virtual Randomized Trial Feasible, Demonstrates Canagliflozin Relieves Symptom Burden in HF
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Associate Professor of Medicine, Harvard Medical School
Recent Article
Lipoprotein(a) Prognostic of CHD in Contemporary Cohort Receiving Menopausal Hormone Therapy
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.